Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C

Table 1 Distribution of patients across seven categorical disease-/therapy-related outcomes

Symbol	Categorical title	Count (n)
SVR	Sustained viral response	16/36
ETR	End of treatment viral response	7/36
VB	Viral breakthrough	5/36
NR	Viral non-response	8/36
Gt. 2,3	HCV genotype 2 or 3	6/36
Fibrosis St. 0,1	Histological stage of hepatic Fibrosis 0 or 1	21/36
	(Batts-Ludwig classification)	21/36
Inflammation Gr. 0,1	Histological grade of hepatic Inflammation 0 or 1	23/36
	(Batts-Ludwig classification)

Table 1 gives the numerical distribution of patients (n = 36), whose samples were subjected to microarray analysis at baseline, among seven groups representing categorical variables as defined under the Methods section.

ISSN: 2047-783X